The database, which had a total of 241 unique samples for MEX3A, and a total of 22 cancers, including brain and CNS cancer, breast cancer, colorectal cancer, and ovarian cancer, showed that MEX3A mRNA levels were significantly upregulated in various cancers, and MEX3A expression in OC was high on top 5 (Figure S1a). This evidence concerns the gene MEX3A and cancer.